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Abstract
Objectives: People who inject drugs (PWID) have poor oral health. However, their Oral Health-
Related Quality of Life (OHRQoL) is unknown. Our study was designed to measure the OHRQoL of 
PWID. 
Methods: The Oral Health Impact Profile-14 (OHIP-14) was administered to 794 PWID recruited in 
Australian capital cities as part of the 2013 Illicit Drug Reporting System. Three OHIP-14 summary 
indicators were examined: ‘Prevalence’ (proportion reporting ≥1 item at least ‘fairly often’), 
‘severity’ (mean total OHIP-14 score), and ‘extent’ (number of impacts reported at least ‘fairly 
often’). Associations between ‘prevalence’ and ‘extent’ and variables drawn from the health, drug 
use and social domains were investigated.  
Results: All OHIP-14 summary indicators among IDRS participants were significantly higher than in 
the general Australian population. In multivariate analysis, the ‘prevalence’ indicator was 
significantly and positively associated with female gender (AOR= 1.75, 95% CI 1.27-2.38), those born 
in Australia (AOR= 2, 95% CI 1.25-3.23-), not completing Year 10 compared to those who had 
completed Year 12 or a higher qualification (AOR= 1.59, 95% CI 1.03-2.44), and methadone 
treatment (AOR= 1.61, 95% CI 1.14-2.29). The ‘extent’ indicator was significantly and positively 
associated with female gender (AIRR= 1.56, 95% CI 1.19-2.08), unemployment (AIRR= 1.59, 95% CI 
1.01-2.44) and having an injecting career of 10-20 years (AIRR= 1.76, 95% CI 1.03-3.01). 
Conclusions: PWID have poorer OHRQoL than the Australian general population. Poor OHRQoL was 
particularly common in female PWID and those with longer injecting careers. Interventions to 
improve the oral health of PWID may improve their OHRQoL. 
Key Words: substance abuse, intravenous; oral health; oral hygiene; Quality of Life; dental care; 
OHRQoL; Australia 
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Introduction 
People who inject drugs (PWID) are much more likely to experience dental problems, such as caries 
and missing and/or filled teeth (1-4), than members of the wider population (1). This is thought to be 
due to a range of factors including unstable accommodation (5), poor oral hygiene habits (6) and 
physiological effects of drug use such as xerostomia or ‘dry mouth’ (2, 7, 8), bruxism (involving teeth 
grinding or jaw clenching) (5, 9), the analgesic effects of opioids and their ability to mask pain 
(therefore delaying treatment until conditions become serious) (5, 10) and impaired recovery from 
oral diseases as a result of opioid use (11).  Poor oral health has not only been found to be 
associated with serious health conditions such as cardiovascular disease (12), coronary heart disease 
(13) and respiratory diseases (14), but is related to wider health and social problems such as speech 
impediments, poor nutrition and low self-image (15). This highlights the importance of these issues 
for PWID, and the need to better understand the impact of these effects.  
Measures that recognise a person’s subjective perspective of how their oral health affects their 
overall health and wellbeing (16) have been developed under the rubric of Oral Health-Related 
Quality of Life (OHRQoL). The assessment of OHRQoL helps define treatment goals that focus on a 
person’s physical functioning as well as their social and emotional experiences. Comparing OHRQoL 
between specific populations allows us to capture the reality of day to day life for people with a 
chronic condition, such as poor oral health, that is relevant to different contexts, providing 
important information for healthcare providers, policy makers and patients (16).  OHRQoL has been 
examined in specific subgroups; for example, people experiencing homelessness have dramatically 
lower OHRQoL than the broader population (17, 18). However, to our knowledge there are no 
published studies of OHRQoL among PWID who, as indicated above, are a highly marginalised 
population with known high prevalence of dental health problems. Evidence about OHRQoL would 
allow the development of clearer strategies for ameliorating this burden, for example by enabling 
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policy makers to assess the need for and benefits of incorporating dental health in PWID-specific 
services (16, 19).  
The aim of this study was to measure the OHRQoL of regular PWID recruited from capital cities 
across Australia. In this paper, we describe the OHRQoL of this population in the context of 
Australian norms using a standardised instrument that measures OHRQoL. We also compare findings 
to a sample of homeless people in South Australia, as homeless people are a group known to report 
poor OHRQoL (17, 18). We then examine associations between OHRQoL and a range of demographic 
and drug use variables. 
 
Methods 
Sample and interviews 
Data were drawn from surveys of 887 PWID conducted in all Australian capital cities as part of the 
2013 Illicit Drug Reporting System (IDRS). One component of the IDRS involves an annual cross-
sectional survey of PWID, typically undertaken over June-August. Eligible participants were required 
to be aged at least 18 years, to report injecting drug use (IDU) at least once per month in the six 
months before interview, be proficient in English and to have lived in the capital city of recruitment 
for the preceding 12 months (20). Participants were recruited through posted advertisement at 
needle and syringe programs (NSPs) in each capital city as well as through snowballing and word of 
mouth (20). Participants were administered a structured, face-to-face questionnaire designed to 
gather detailed information on demographics, drug use and various related health outcomes that 
took approximately one hour to complete. Further details on the study can be found elsewhere (20). 
Outcome variables 
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The Oral Health Impact Profile (OHIP) is a validated patient-oriented instrument that measures 
OHRQoL; the short version of this instrument, the Oral Health Impact Profile – 14 (OHIP-14), is often 
used in population-level studies. Outcome variables were derived from the OHIP-14 (21) included in 
the 2013 IDRS questionnaire.  The OHIP-14 is comprised of 14 items that measure the negative 
impacts on physical, psychological and social dimensions resulting from problems relating to the 
mouth, teeth and dentures. The OHIP-14 enhances our understanding of the relationship between 
general health and oral health by allowing measurement of the quality of an individual’s wellbeing as 
related to their dental health, as it extends beyond simply counting or measuring problematic dental 
conditions (16).   
Participants were asked how often they experienced a particular negative impact due to their oral 
health in the past three months. For example, the first item asks “How often during the last three 
months have you had trouble pronouncing any words because of problems with your teeth, mouth 
or dentures?” Five point rating scales are used for each item: from ‘Never’, ‘Hardly ever’, 
‘Occasionally’, ‘Fairly often’ to ‘Very often’ that are subsequently assigned the scores of 0, 1, 2, 3 and 
4 respectively (22).  
Three summary indicators were generated from the OHIP-14 (see Table 1), as used in previous 
research (21): 
1. ‘Prevalence’: The percentage of people reporting one or more of 14 items ‘fairly often’ or 
‘very often’. Responses were dichotomised into two groups (i.e. only responses coded as 3 
or 4 were counted for ‘prevalence’); 
2. ‘Severity’: The sum of a participant’s ordinal responses, which can range from 0 to 56, with 
higher scores reflecting poorer OHRQoL; and 
3. ‘Extent’: The number of impacts (items) reported at least ‘fairly often’. 
Potential correlates 
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Associations between a range of demographic and drug use variables and OHIP-14 scores were 
examined. The independent variables reflect those used in similar studies with the same population 
group and are listed in Table 2, along with the categorisations used in analysis (23). The 
categorisations are self-explanatory except for the following. Average weekly income was coded to 
reflect the ‘low income’ referent used by the Australian Bureau of Statistics (24); as seen in Tables 2 
and 3, the ‘$400+’ variable was used to define amounts higher than ‘low income’; the 
methamphetamine use variable categories (MA use frequency) included the three forms available in 
Australia – ice (crystalline), speed (powder) and base (damp or oily substance); the ‘Other’ category 
for less frequent responses to ‘Drug injected most often last month’ included pharmaceutical opioids 
such as methadone, buprenorphine, buprenorphine-naloxone, morphine and oxycodone, as well as 
cocaine, benzodiazepines and other combination drug cocktails; and the ‘Other’ category for ‘Drug 
of choice’ included pharmaceutical opioids such as methadone, buprenorphine, buprenorphine-
naloxone, morphine and oxycodone and other opioids not listed, as well as cocaine, LSD, ecstasy, 
benzodiazepines, alcohol, cannabis and other drugs not listed.  
Analysis 
All cases with non-missing values for each outcome and predictor variable were included in the 
dataset, producing a final sample of 794. Descriptive statistics were generated for the three 
summary indicators of the OHIP-14 and were compared with the latest available OHIP-14 results for 
the Australian general population (2004-2006 National Survey of Adult Oral Health (NSAOH)). To 
enable comparison with another group with known poor oral health (25) and lower OHIP-14 scores 
than the general population (17, 18) summary indicators were also compared with a sample of 
homeless people in South Australia (SA). Stata® 11.0 was used to perform all analyses. 
Associations between the independent variables and ‘prevalence’ were investigated using 
multivariate logistic regression. Negative binomial regression was chosen for the equivalent analysis 
Truong, A., Higgs, P., Cogger, S., Burns, L., Jamieson, L. & Dietze, P. 2015. Oral Health-Related Quality of Life among an 
Australian sample of people who inject drugs, Journal of Public Health Dentistry, doi: 10.1111/jphd.12092  7 
 
of the ‘extent’ variable, as initial analysis showed that these data were over-dispersed (26). Initial 
inspection of the ‘severity’ variable revealed many zero scores that highly skewed the distribution, 
precluding further examination of this outcome. 
The same independent variables were included for both bivariate and multivariate analyses of 
‘extent’ and ‘prevalence’. Statistical significance was set at the p<0.05 level. For the logistic 
regression models, results were reported as odds ratios (OR) and adjusted odds ratios (AOR); for the 
negative binomial regression models, results were reported as incidence rate ratios (IRR) and 
adjusted incidence rate ratios (AIRR). 
Ethics 
Ethical approvals for this study were obtained from Human Research Ethics Committees of the 
[blinded for review], and the overall IDRS study is approved by the [blinded for review] Human 
Research Ethics Committee. 
 
Results 
Overall OHIP scores and summary indicators 
Table 1 shows that this sample of PWID fared significantly worse on all three OHIP-14 summary 
indicators than the general Australian population (27). However, IDRS participants had significantly 
lower scores across all OHIP measures than a population of homeless people in South Australia (17, 
18).  
Table 1 about here 
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Correlates of OHIP-14 ‘prevalence’ 
Table 2 shows that a range of variables were associated with ‘prevalence’ at a bivariate level. 
However, after adjusting for all of the variables included in the model, only a few significant 
associations remained. ‘Prevalence’ was higher among females than males, as it was for those who 
were born in Australia compared to those born outside Australia. Participants who completed Year 
12 or a higher qualification were more likely to report ‘prevalence’ when compared to those who did 
not complete Year 10. A greater proportion of participants who reported being on methadone 
maintenance treatment at the time of their interview reported ‘prevalence’ than those who were 
not on any form of drug treatment. 
Table 2 about here 
 
Correlates of OHIP-14 ‘extent’ 
Table 3 shows that a range of variables were associated with ‘extent’ at a bivariate level. However, 
after adjusting for all variables included in the model, only a few associations remained. 
In multivariate analysis, the ‘extent’ scores of females were higher than those of males, as were the 
‘extent’ scores of those who were unemployed compared to those who were employed. Participants 
who reported an injecting career of between 10 and 20 years had higher ‘extent’ scores than those 
who reported injecting for less than 10 years.  
Table 3 about here 
 
Discussion 
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OHRQoL, as measured by OHIP-14 scores, was significantly worse among our sample of Australian 
PWID than the general population. Nevertheless, scores were not as low as in a sample of homeless 
people recruited in South Australia (17). Interestingly, when accommodation status was entered into 
our regression analyses, participants who reported ‘no fixed address’ generally showed poorer 
OHRQoL than other participants, but this difference failed to reach significance. This probably 
reflects the relatively small number of participants who reported ‘no fixed address’ in our sample, 
and an associated lack of statistical power to detect any effects. 
We also found a consistent pattern of poorer OHRQoL among females in our study. This finding 
contrasts with previous Australian research undertaken by Sanders et al. who found no statistically 
significant gender differences in OHIP-14 results (28). Previous research highlights poor oral health 
among PWID (1). Our findings suggest that subjective perceptions and life impacts of this poor oral 
health, such as feeling self-conscious when interacting with others, may be worse for female than for 
male PWID. This would be consistent with gender-based issues around body image more generally, 
which show that poor body image impacts more on females than males (29).  
Being employed at the time of interview was significantly associated with reporting fewer OHIP-14 
items ‘fairly often’ or ‘very often’ (the ‘extent’ measure). This finding is consistent with that of 
Shekarchizadeh et al. (30) who found that among people who used drugs, those who were 
unemployed had the poorest oral health behaviours. Employment is a marker of higher 
socioeconomic status among PWID.  We found consistent effects of higher socioeconomic status, 
with those who reported completing Year 12 or a higher qualification being less likely to report 
‘prevalence’ than those who did not complete Year 10. These findings are consistent with other 
research showing higher rates of dental service utilisation among more highly educated groups in 
the community (31).  
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We found that PWID who were born in a country other than Australia were less likely to report 
‘prevalence’ after adjusting for the effects of other variables.  We were unable to disaggregate this 
variable further, however, with over 11 different countries of birth reported by participants.  Further 
research focusing on specific dental health practices by PWID of different ethnicities is required to 
better understand this relationship. 
Interestingly, frequencies of heroin or methamphetamine use were not significantly associated with 
poorer OHRQoL, suggesting that lifestyle factors and personal circumstances are more important for 
OHRQoL for PWID than drug types used and the physiological effects associated with them. 
However, it should be noted that the specific oral health effects of different drug types may be 
masked by the fact that many participants in the IDRS sample have long histories of polydrug 
injection (20). 
Even after adjusting for age, we found that an injecting career of between 10 and 20 years to be 
significantly associated with the ‘extent’ outcome when compared with an injecting career of less 
than 10 years (with a similar, non-significant, pattern evident for ‘prevalence’). However, although 
the pattern was similar, the differences between an injecting career of more than 20 years and a 
career of less than 10 years failed to reach significance. These findings contrast with those of Laslett 
et al. (1) who found that injecting career was not related to dental problems. However, Laslett et al. 
examined only past-year dental problems, whereas our findings suggest that it is the cumulative 
effect of a longer injecting career on oral health that may lead to sustained impacts on OHRQoL. 
We found that participants in current methadone treatment were significantly more likely to report 
poorer OHRQoL than those not in drug treatment (Table 2). This relationship was maintained even 
after adjusting for type and frequency of other drug use. Previous research has shown that people in 
current methadone treatment exhibit poor dental health (4, 32) and poor oral health behaviours (i.e. 
not brushing teeth, not flossing, and eating sugary products) (30), but there is no evidence to 
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suggest that their oral health behaviour would be worse compared to those not in treatment. 
Further, the formulation of methadone for Australian programs changed in July 1994 (sorbitol 
replaced sucrose, rendering the preparation sugar-free) in response to concerns about its high sugar 
content (33), meaning that sugar exposure through methadone delivery is unlikely to underpin any 
differences. Further work is needed to unpack and understand the relationship between methadone 
treatment utilisation and OHRQoL we observed.  
The OHIP-14 module used in this study was limited to outcomes experienced by participants in the 
preceding three months. Additionally, although the IDRS survey is designed to be easily understood, 
recall bias remains a possible limitation, together with the subjective nature of the OHIP-14 in 
relation to assessing the social impacts of oral health. Further, as with most research involving PWID, 
the nature of the recruitment and sampling used in this study means that it is not possible to 
determine the extent to which the IDRS sample are representative of PWID more broadly (20). 
 
Conclusion 
Our study indicates that PWID have significantly poorer OHRQoL than the Australian general 
population. PWID need access to high-quality and timely dental services, ideally involving people 
skilled in working with vulnerable populations, to improve their OHRQoL. However, our study shows 
a range of factors are related to the OHRQoL of PWID such as education, employment and length of 
injecting career. These factors should be taken into consideration in policy and practice, for example 
through enhancing existing PWID-specific primary care or related services, with a specific focus on 
the OHRQoL of female PWID. These findings form an important step forward toward further 
research to develop interventions to improve this essential aspect of overall health and wellbeing of 
PWID.   
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†Crocombe et al. (2013), weighted data presented (27)  





  2013 IDRS 
(n=794)  
2004-06 NSAOH † 
(n=3295) 
SA Homeless ‡ 
(n=248) 
Prevalence  % 95% CI  % 95% CI % 95% CI 
  48 (45-52)  19 (17-21) 91 (87-95) 
Extent  mean 95% CI  mean 95% CI mean 95% CI 
  2.5 (2.2-2.7)  0.5 (0.4-0.6) 9.3 (8.7-9.9) 
Severity  mean 95% CI  mean 95% CI mean 95% CI 
  13.5 (12.5-14.5)  7.6 (7.1-8.1) 21.6 (19.8-23.4) 
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Table 2: Distribution of ‘prevalence’ scores across key sociodemographic and drug use variables, 
along with logistic regression results. 
n=794 n(%) Report 
‘prevalence’ 
OR (95% CI) AOR (95%CI) 
Gender          
 Female 161 (56) Ref.      
 Male 223 (44) 0.61 (0.45-0.81) 0.57 (0.42-0.79) 
Age          
 <30 37 (43) Ref.      
 30-39 133 (46) 1.14 (0.70-1.85) 1.08 (0.56-2.09) 
 40+ 214 (51) 1.38 0.86-2.20) 1.60 (0.71-3.62) 
Accommodation         
 Stable 289 (48) Ref.      
 Unstable 41 (41) 0.74 (0.48-1.13) 0.71 (0.45-1.13) 
 Homeless 54 (55) 0.97 (0.70-1.34) 1.33 (0.84-2.13) 
Country of birth         
 Australia 346 (51) Ref.      
 Other 38 (35) 0.52 (0.34-0.79) 0.50 (0.31-0.80) 
Language spoken at home         
 English 375 (49) Ref.      
 Other 9 (27) 0.39 (0.18-0.84) 0.51 (0.22-1.17) 
ATSI          
 No 315 (48) Ref.      
 Yes 69 (51) 1.16 (0.80-1.69) 0.90 (0.60-1.35) 
Highest level of education 
 <Year 10 149 (54) Ref.      
 Year 10-11 165 (46) 0.73 (0.53-0.99) 0.74 (0.53-1.04) 
 Year 12/higher/trade 70 (42) 0.62 (0.42-0.91) 0.63 (0.41-0.97) 
Employment          
 No 349 (50) Ref.      
 Yes 35 (39) 0.65 (0.41-1.01) 0.68 (0.42-1.12) 
Income (average weekly amount)         
 0-249 113 (50) Ref.      
 250-399 144 (47) 0.89 (0.63-1.26) 0.84 (0.58-1.22) 
 400+ 127 (49) 0.99 (0.69-1.41) 0.95 (0.64-1.41) 
Age first injected         
 Continuous   1.00 (0.98-1.02) 1.00 (0.97-1.04) 
Length of injecting career 
 <10 years 38 (37) Ref.      
 10 - 20 years 161 (52) 1.83 (1.16-2.90) 1.83 (0.97-3.44) 
 >20 years 185 (48) 1.57 (1.00-2.47) 1.35 (0.59-3.10) 
Drug of choice         
 Heroin 212 (50) Ref.      
 Other 104 (53) 1.12 (0.80-1.57) 1.32 (0.84-2.08) 
 Methamphetamine 68 (39) 0.62 (0.44-0.89) 0.60 (0.34-1.09) 
Drug injected most often last month 
 Heroin 169 (52) Ref.      
 Other 126 (48) 0.85 (0.62-1.18) 1.07 (0.62-1.85) 
 Methamphetamine 89 (44) 0.73 (0.51-1.04) 0.97 (0.48-1.95) 
MA use frequency (last 6 months) 
 No use 145 (49) Ref.      
 < Fortnightly 84 (46) 0.88 (0.61-1.28) 0.99 (0.67-1.48) 
 Fortnightly or more 155 (49) 0.98 (0.71-1.34) 1.48 (0.96-2.28) 
Heroin use frequency (last 6 months) 
 No use 143 (45) Ref.      
 < Fortnightly 42 (43) 0.89 (0.56-1.40) 0.83 (0.51-1.36) 
 Fortnightly or more 199 (52) 1.32 (0.98-1.78) 1.32 (0.78-2.24) 
Current drug treatment         
 N/A 189 (44) Ref.      
 Methadone 145 (58) 1.71 (1.25-2.34) 1.61 (1.14-2.29) 
 Other 9 (43) 0.94 (0.39-2.29) 1.36 (0.53-3.54) 
 Buprenorphine 41 (44) 0.97 (0.62-1.53) 1.06 (0.65-1.72) 
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Table 3: Distribution of ‘extent’ scores across key sociodemographic and drug use variables, along 
with negative binomial regression results. 
n=794     IRR (95% CI)     AIRR (95% CI) 
Gender       
 Female  Ref.     
 Male 0.66 (0.51-0.86)  0.64 (0.48-0.84) 
Age       
 <30 Ref.     
 30-39 1.09 (0.70-1.70)  1.05 (0.62-1.79) 
 40+ 1.24 (0.81-1.92)  1.24 (0.63-2.44) 
Accommodation       
 Stable Ref.     
 Unstable 0.81 (0.55-1.21)  0.85 (0.57-1.26) 
 Homeless 1.24 (0.84-1.82)  1.37 (0.93-2.03) 
Country of birth       
 Australia Ref.     
 Other 0.7 (0.48-1.02)  0.73 (0.49-1.08) 
 Language spoken at home      
 English Ref.     
 Other 0.67 (0.35-1.29)  0.57 (0.29-1.12) 
ATSI       
 No Ref.     
 Yes 1.36 (0.97-1.91)  1.17 (0.83-1.65) 
Highest level of education      
 <Year 10 Ref.     
 Year 10-11 0.82 (0.62-1.10)  0.79 (0.59-1.05) 
 Year 12/higher/trade 0.77 (0.54-1.10)  0.74 (0.51-1.06) 
Employment       
 No Ref.     
 Yes 0.58 (0.38-0.87)  0.64 (0.42-0.99) 
Income (average weekly amount)      
 0-249 Ref.     
 250-399 1.00 (0.73-1.37)  1.02 (0.74-1.41) 
 400+ 0.91 (0.65-1.26)  0.88 (0.62-1.24) 
Age first injected       
 Continuous 1.01 (0.99-1.03)  1.02 (0.99-1.05) 
Length of injecting career      
 <10 years Ref.     
 10-20 years 1.36 (0.90-2.06)  1.76 (1.03-3.01) 
 >20 years 1.22 (0.81-1.84)  1.66 (0.80-3.45) 
Drug of choice       
 Heroin Ref.     
 Other 1.18 (0.87-1.61)  1.45 (0.97-2.19) 
 Methamphetamine 0.75 (0.54-1.04)  0.88 (0.53-1.46) 
Drug injected most often last month      
 Heroin Ref.     
 Other  0.91 (0.68-1.23)  0.89 (0.55-1.46) 
 Methamphetamine 0.76 (0.55-1.05)  0.72 (0.40-1.28) 
MA use frequency (last 6 months)      
 No use Ref.     
 < Fortnightly 0.91 (0.65-1.28)  0.86 (0.61-1.22) 
 Fortnightly or more 0.99 (0.74-1.32)  1.34 (0.94-1.92) 
Heroin use frequency (last 6 months)      
 No use Ref.     
 < Fortnightly 0.81 (0.53-1.24)  0.86 (0.56-1.32) 
 Fortnightly or more 1.15 (0.87-1.51)  1.16 (0.74-1.83) 
Current drug treatment      
 N/A Ref.     
 Methadone 1.21 (0.91-1.61)  1.31 (0.96-1.77) 
 Other 0.56 (0.24-1.30)  0.79 (0.33-1.86) 
 Buprenorphine 1.12 (0.74-1.68)  1.36 (0.90-2.07) 
 
 
 
